Report 004 · Supplement Reality Check
What a good lion's mane trial actually found
A rigorous, placebo-controlled trial gave healthy adults a single dose of lion's mane and measured them carefully. The headline results were flat. Here's what the label copy quietly rests on instead.
By Onur Oncer
Published 2026-07-04
Read 4 min
Disclosure first, because it matters here: I formulate functional-mushroom supplements for a living. I have a commercial interest in this category. That's exactly why I hold the evidence (especially the studies that cut against the marketing) to the same standard I'd want a skeptic to use on me. So let's read one of those studies.
Lion's mane (Hericium erinaceus) is sold, more or less openly, as a same-day brain upgrade. If you want to know what's underneath that promise, the most rigorous recent human test is a good place to look: a double-blind, placebo-controlled, crossover randomized trial published in Frontiers in Nutrition in 2025. The design is the kind you want: everyone gets both the real thing and placebo on separate days, nobody knows which is which, and each person is their own control. Healthy young adults (18 of them, aged 18–35) took a single 3 g acute dose of a concentrated fruiting-body extract, and researchers measured cognition and mood 90 minutes later.
What it found
The two things the study set out to measure (its pre-registered primary outcomes) both came back flat. In the authors' own words, there was "no significant main effect... for the composite measure of global cognitive function (all p > 0.05) and the composite measure of mood (all p > 0.05)." Sharper thinking, better mood (the exact things the ads promise) did not move versus placebo.
One thing did move. On a single secondary task (the dominant-hand Grooved Pegboard, a test of fine-motor speed, basically how fast your hand can drop pegs into holes) the lion's mane condition beat placebo at the 90-minute mark. That's it. That's the sliver. And notice what it is: a manual-dexterity result, not a thinking-or-mood result. If you ever see lion's mane packaging say something is "clinically shown," this is the kind of finding that phrase is often built on: one secondary outcome, in one small study, pointing the right way.
The authors themselves draw the line clearly:
"Acute consumption of H. erinaceus fruiting body did not demonstrate a significant overall improvement in cognitive performance and mood compared to the placebo and any benefits may be task or domain specific."
The honest caveat
Now the part where I hold myself to my own rule, because this cuts both ways. This trial was acute: a single dose, measured once. It was small: 18 people. And the participants were healthy and young, 18 to 35. So here's what it does not do: it does not refute the idea that taking lion's mane every day for weeks might do something. Chronic, build-up-over-time effects are a completely different question, and this study never asked it. It also says nothing about older adults or people with actual cognitive impairment: they weren't in the room.
What it does do is narrow and clean: it shows that a one-off dose of lion's mane is not an acute nootropic. If a product implies you'll feel your thinking sharpen the afternoon you take a single capsule, this is the trial that quietly says otherwise.
The signal
Here's the move I'd offer for reading any supplement claim, mine included. When you see a benefit stated, ask three questions the study either answers or doesn't: Did they test the way you'd actually use it: one dose, or daily for months? Did they test people like you: healthy 22-year-olds, or your situation? And which number actually moved: the main thing they set out to measure, or one secondary result that happened to land? "Clinically shown" is not a lie when it points at a real p-value. It just very often points at the pegboard, not the promise.
I'd rather sell you a mushroom with honest expectations than a headline you'll feel let down by. The category has real, interesting science in it. It also has a lot of copy written well ahead of the data. Telling those apart is the entire job.
Disclosure, again, plainly: I founded and run Shroombiosis (a company I run), which formulates and sells functional-mushroom supplements, so I have a commercial stake in this category. Nothing here is sponsored and no link earns a commission; here's the full policy. And a recommendation with no stake at all: if performance nutrition is your thing (a different category from what I make), Die Tryin Co. is a fellow combat-veteran-owned brand I'm glad to point you to; I don't own it and earn nothing from the link.
Not medical advice. This is educational analysis, not a recommendation — a study is not a prescription. Talk to a qualified clinician before acting on anything you read here. Full disclaimer →
Onur Oncer
U.S. Army combat veteran (Counter-IED / Electronic Warfare), peer-reviewed researcher in microwave spectroscopy, and founder & CEO of Shroombiosis. Consults on laboratory operations, AI, and supplement formulation.